Skip to Content

Join the 'Chronic Obstructive Pulmonary Disease, Maintenance' group to help and get support from people like you.

Chronic Obstructive Pulmonary Disease, Maintenance News

Related terms: COPD, Maintenance

Study Casts Doubt on Effectiveness of COPD Drug

Posted 5 days ago by Drugs.com

TUESDAY, Feb. 2, 2016 – A widely used drug may not significantly reduce the amount of time that patients with the lung condition COPD require mechanical help to breathe, a new study suggests. COPD (chronic obstructive pulmonary disease) – which is often related to smoking – includes emphysema, chronic bronchitis or a combination of the two. Common symptoms include difficulty breathing, chronic cough, wheezing and phlegm production. Over time, the condition can prove fatal. The drug acetazolamide has been used for decades to help COPD patients breathe when they develop a dangerous condition called metabolic alkalosis. However, the French study authors said that, until now, there's been no clinical trial to prove that the drug is actually effective in such cases. To try to remedy that situation, the new study included 380 French COPD patients who were expected to receive mechanical ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Diamox, Acetazolamide, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Diamox Sequels

Implanted Lung Valves Show Promise in Some Emphysema Patients

Posted 9 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 9, 2015 – New research suggests that more careful selection of patients could help improve the success rate of valves implanted into the lungs of people with emphysema. The valves aim to improve breathing, allowing patients with the chronic lung disease to be more active and to perhaps survive longer. Previous research into the valves has been mixed, but the new Dutch study found that they work more effectively if physicians are more selective about which patients get them. "The results are relatively impressive," said lung physician Dr. Gary Hunninghake, an assistant professor at Harvard Medical School in Boston. "These are benefits that physicians would want to get, and patients might feel better. This could result in people being more enthusiastic about this technique." However, the valves come with a risk of serious side effects, the study authors noted, and the ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Diagnosis and Investigation, Respiratory Failure, Mechanical Ventilation, Bronchospastic Disease, Respiratory Arrest

Agricultural Pesticides May Affect Kids' Breathing

Posted 3 Dec 2015 by Drugs.com

THURSDAY, Dec. 3, 2015 – Early exposure to widely used pesticides may harm children's lungs, a new study says. Previous research has looked at the harmful effect of organophosphate pesticides – chemicals that target the nervous system – on adult agricultural workers. This new study looked at children living in an agricultural area where the organophosphates are used. "This is the first evidence suggesting that children exposed to organophosphates have poorer lung function," said study senior author Brenda Eskenazi, a professor of epidemiology and of maternal and child health at the University of California, Berkeley. For this study, researchers measured levels of organophosphate pesticides in urine samples collected on five occasions from 279 children in California's Salinas Valley between the ages of 6 months and 5 years. The area is an agricultural hub, producing lettuce, grapes, ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Pneumonia, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Asthma - Acute, Sore Throat, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Respiratory Distress Syndrome, Croup, Diagnosis and Investigation, Respiratory Failure, Reversible Airways Disease - Maintenance, Reversible Airways Disease

Pollution From Coal Burning Most Damaging to Health, Study Finds

Posted 2 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 2, 2015 – Air pollution particles from the burning of coal are far more dangerous to your health than those from other sources, a new study indicates. Researchers analyzed data gathered from 450,000 people in 100 U.S. cities between 1982 and 2004. The team from NYU Langone Medical Center, in New York City, found that exposure to tiny particles in fossil fuel emissions are associated with an increased risk of heart disease. Fossil fuels include coal, crude oil and natural gas. The investigators found that – pound for pound – particles from coal burning contribute about five times more to the risk of death from heart disease than other air pollution particles of the same size – less than one ten-thousandth of an inch in diameter (known as PM 2.5). The findings were published online Dec. 2 in the journal Environmental Health Perspectives, just as world leaders gather in ... Read more

Related support groups: Cough, Smoking, Chronic Obstructive Pulmonary Disease, Maintenance, Cough and Nasal Congestion, Chronic Obstructive Pulmonary Disease, Acute, Respiratory Tract Disease, Reversible Airways Disease

FDA Approves Seebri Neohaler (glycopyrrolate) for COPD

Posted 4 Nov 2015 by Drugs.com

EAST HANOVER, N.J., Oct. 29, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved Seebri Neohaler (glycopyrrolate) inhalation powder 15.6 mcg as a stand-alone monotherapy for COPD. Novartis expects that Seebri Neohaler will be available in the first quarter of 2016. Seebri is delivered via the low resistance Neohaler inhaler, which makes it suitable for patients with different severities of airflow limitation. About Seebri Neohaler Seebri Neohaler, previously known as NVA237, is a twice-daily long-acting muscarinic antagonist (LAMA) for the long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema. Glycopyrrolate (also known as glycopyrronium bromide) was exclusively licensed to Novartis in April 2005 by Vectura and its co-development partner Sosei. About Novartis Respiratory ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Glycopyrrolate, Seebri Neohaler

FDA Approves Utibron Neohaler (indacaterol/glycopyrrolate) for COPD

Posted 4 Nov 2015 by Drugs.com

EAST HANOVER, N.J., Oct. 29, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD. "Patients have told us about the tremendous impact their COPD can have on everyday activities," said Christi Shaw, US Country Head, President of Novartis Corporation and Novartis Pharmaceuticals Corporation. "With this approval, the COPD community now has a new medicine that can help so many patients by improving not only their symptoms, but also their health-related quality of life. This means the possibility of doing things that matter ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Utibron Neohaler, Glycopyrrolate/indacaterol

Tai Chi Might Help People With Long-Term Health Conditions

Posted 17 Sep 2015 by Drugs.com

THURSDAY, Sept. 17, 2015 – The slow, fluid movements of tai chi – an ancient Chinese exercise – appear to help older adults with chronic conditions improve their physical function, a new review suggests. Specifically, those with breast cancer, heart failure, osteoarthritis or chronic obstructive pulmonary disease (COPD, which includes emphysema) saw improvements in strength, balance and posture without worsening pain or being out of breath, researchers said. "If you're older and have one of the conditions mentioned in the study, tai chi may be an alternative you can use to increase your fitness level," said senior researcher Darlene Reid, professor and chair of the Department of Physical Therapy at the University of Toronto in Canada. Tai chi is a series of gentle, flowing movements that aim to improve muscle power, balance, posture and flexibility, she said. In addition, tai chi has ... Read more

Related support groups: Osteoarthritis, Chronic Obstructive Pulmonary Disease, Breast Cancer, Heart Failure, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, Maintenance, Left Ventricular Dysfunction, Chronic Obstructive Pulmonary Disease, Acute, Breast Cancer, Prevention

No Evidence to Support Widespread Screening for COPD: Experts

Posted 17 Aug 2015 by Drugs.com

MONDAY, Aug. 17, 2015 – Chronic obstructive pulmonary disease (COPD) – a serious disease that impairs breathing – is the third leading cause of death in the United States. But an influential government panel says there's as yet no evidence to support screening for COPD in adults with no symptoms. In a draft recommendation released Monday, the U.S. Preventive Services Task Force said the panel had reviewed the latest evidence and saw no reason to change its earlier recommendation on COPD screening, issued in 2008. "The task force found that there is no evidence that screening for COPD in adults without symptoms results in improved health outcomes," member Dr. William Phillips said in a news release from the independent panel of experts. COPD includes emphysema, chronic bronchitis or a combination of the two. Common symptoms include difficulty breathing, chronic cough, wheezing and ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Fireworks Can Spark Bump in Air Pollution, Study Finds

Posted 1 Jul 2015 by Drugs.com

WEDNESDAY, July 1, 2015 – Most Americans know that fireworks can injure the eyes and hands, but these Fourth of July favorites can also take a toll on the lungs, a new study finds. Researchers from the National Oceanic and Atmospheric Administration (NOAA) found fireworks produce air pollutants, including tiny particles found in the air known as particulate matter. These microscopic particles of dust, dirt, soot, smoke and liquids can get inside the lungs and cause coughing, wheezing and shortness of breath. They can also lead to long-term health issues, such as asthma attacks, heart attack, stroke and even death in those with heart or lung disease. Using observations from 315 U.S. air quality-monitoring sites recorded from 1999 to 2013, the NOAA researchers quantified the surge in particulate matter that occurred on the nation's birthday. Specifically, they looked for particles that ... Read more

Related support groups: Asthma, Heart Disease, Chronic Obstructive Pulmonary Disease, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Maintenance, Asthma - Acute, Chronic Obstructive Pulmonary Disease, Acute, Allergic Asthma, Ischemic Heart Disease, Reversible Airways Disease, Reversible Airways Disease - Maintenance

Health Tip: When Air Is Unhealthy

Posted 23 Jun 2015 by Drugs.com

-- Poor outdoor air quality may spur breathing problems among people with asthma or other respiratory issues. The American Lung Association advises: Be aware of the air quality and pollution levels each day in your area. Exercise indoors when air quality is poor, and restrict outdoor playtime for children. Cut down on driving by carpooling, biking or walking to work. Avoid burning wood or trash, and use battery-powered or electric lawn machinery instead of gas-powered devices. Keep indoor air quality healthier by prohibiting smoking at home. Read more

Related support groups: Asthma, Smoking, Chronic Obstructive Pulmonary Disease, Smoking Cessation, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Maintenance, Asthma - Acute, Chronic Obstructive Pulmonary Disease, Acute, Allergic Asthma, Reversible Airways Disease, Reversible Airways Disease - Maintenance

Millions of Smokers May Have Undiagnosed Lung Disease

Posted 22 Jun 2015 by Drugs.com

MONDAY, June 22, 2015 – Millions of long-term smokers may have undiagnosed lung disease, a new study finds. Fifty-five percent of those who pass lung function tests still have a respiratory impairment, researchers report. But, using advanced imaging techniques along with walking and quality-of-life tests can reveal early signs of chronic obstructive pulmonary disease (COPD). An incurable, progressive disease, COPD is associated with smoking and is the third-leading cause of death in the United States, the researchers added. "Smokers who have 'normal' lung-function tests often have significant respiratory disease. Many of those smokers likely have the early stages of chronic obstructive pulmonary disease," study author Dr. Elizabeth Regan, an assistant professor of medicine at National Jewish Health in Denver, said in a hospital news release. "We hope these findings will help debunk the ... Read more

Related support groups: Smoking, Chronic Obstructive Pulmonary Disease, Smoking Cessation, Chronic Obstructive Pulmonary Disease, Maintenance, Lung Cancer, Chronic Obstructive Pulmonary Disease, Acute

COPD Patients Less Active, Which Can Worsen Outcomes

Posted 17 Jun 2015 by Drugs.com

WEDNESDAY, June 17, 2015 – People with chronic obstructive pulmonary disease (COPD) become less physically active, leading to further declines in their health, a new study shows. Decreased physical activity results in worsening lung function and overall health. Sustained inactivity is also associated with progression of muscle loss and inability to exercise, the researchers said. Their study of more than 130 people with COPD found that their physical activity decreased each year. The declines occurred regardless of the severity of their disease. Reduced physical activity was associated with an increase in breathing problems and decreases in overall health, quality of life and sense of well-being. Long-term physical inactivity was associated with larger declines in muscle mass and in 6-minute walk distance results. The study was published online recently in the American Journal of ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

FDA Approves Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray for COPD

Posted 26 May 2015 by Drugs.com

RIDGEFIELD, Conn., May 26, 2015 – Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray. It has been approved as a long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Stiolto Respimat is not indicated to treat asthma or acute deterioration of COPD. COPD, which includes chronic bronchitis and emphysema, is a serious but treatable lung disease. More than 15 million Americans have been told that they have COPD, but as many as 45 percent of the total estimated COPD cases in the U.S. remain undiagnosed. Patients are typically diagnosed when lung function is already significantly impaired. COPD symptoms can negatively impact a patient’s ability to br ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Spiriva HandiHaler, Tiotropium, Olodaterol

COPD Raises Cardiac Death Risk for Those With Irregular Heartbeat

Posted 20 May 2015 by Drugs.com

WEDNESDAY, May 20, 2015 – Chronic obstructive pulmonary disease (COPD) increases the risk of all-cause and heart-related death in people with the common heart rhythm disorder known as atrial fibrillation, a new study finds. However, COPD doesn't increase the risk of stroke, the researchers said. COPD is a term used to describe the diseases emphysema and chronic bronchitis. COPD is the third leading cause of death in the United States, according to the U.S. Centers for Disease Control and Prevention. "Other studies have shown that COPD is an independent risk factor for cardiovascular disease, but what hadn't been studied was whether COPD was an independent risk factor for stroke, specifically among patients with atrial fibrillation," study author Dr. Michael Durheim, a pulmonary and critical care fellow at Duke University in Durham, N.C., said in an American Thoracic Society news ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Atrial Fibrillation, Arrhythmia, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Rural Poor Bear Higher Burden of COPD, Study Finds

Posted 19 May 2015 by Drugs.com

TUESDAY, May 19, 2015 – Being poor and living in a rural area are two risk factors for chronic obstructive pulmonary disease (COPD), a new study finds. COPD is a progressive and incurable lung condition that involves a combination of emphysema and chronic bronchitis. It is often linked to smoking, and is the third leading cause of death in the world. In the new study, researchers led by author Dr. Sarath Raju of the Johns Hopkins School of Medicine in Baltimore reviewed data from almost 88,000 American adults older than 40. They found that 7.2 percent of them had COPD. However, the rate of COPD was closer to 12 percent among those who lived in poor and rural areas, Raju's team found. Why would people in rural areas be at higher risk? The reasons aren't clear, the team said. They said there's a need for research "to understand the potential contribution of occupational exposures, fuel ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease

Related Drug Support Groups

albuterol, Symbicort, Spiriva, Ventolin, Advair Diskus, Advair HFA, Combivent, Xopenex, ProAir HFA, view more... Daliresp, ipratropium, Atrovent, Proventil, salmeterol, Ventolin HFA, tiotropium, glycopyrrolate, DuoNeb, Brovana, Proventil HFA, Alupent, formoterol, Tudorza Pressair, Serevent Diskus, Foradil Aerolizer, Atrovent HFA, albuterol / ipratropium, levalbuterol, fluticasone / salmeterol, Ipratropium Inhalation Solution, Xopenex HFA, Volmax, roflumilast, Combivent Respimat, Spiriva Respimat, Ipratropium Inhalation Aerosol, Utibron Neohaler, Seebri Neohaler, ProAir RespiClick, Arcapta, arformoterol, Perforomist, aclidinium, glycopyrrolate / indacaterol, Airet, AccuNeb, Vospire ER, indacaterol, Xopenex Concentrate, Metaprel, Respirol, metaproterenol, budesonide / formoterol